| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 27.239 | 40.904 | 31.748 | 25.490 | 25.648 | 21.514 | 25.912 | 27.454 | 26.389 | 20.727 |
| Total Income - EUR | 27.239 | 40.904 | 31.748 | 25.492 | 25.648 | 21.514 | 25.912 | 27.454 | 26.389 | 20.727 |
| Total Expenses - EUR | 3.813 | 10.277 | 9.834 | 9.883 | 9.834 | 8.855 | 8.347 | 5.072 | 10.486 | 11.608 |
| Gross Profit/Loss - EUR | 23.425 | 30.627 | 21.915 | 15.610 | 15.814 | 12.659 | 17.565 | 22.382 | 15.903 | 9.119 |
| Net Profit/Loss - EUR | 22.608 | 29.809 | 20.415 | 14.845 | 15.313 | 12.255 | 16.881 | 21.724 | 15.644 | 8.510 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Ager Med Ob-Gin Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.106 | 714 | 420 | 262 | 110 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 2.727 | 14.930 | 29.929 | 18.876 | 17.156 | 14.635 | 31.187 | 23.487 | 16.865 | 9.811 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 2.164 | 10.646 | 13.592 | 4.660 | 17.115 | 692 | 1.851 | 17.442 | 12.220 | 8.949 |
| Cash | 563 | 4.284 | 16.337 | 14.216 | 41 | 13.944 | 29.336 | 6.045 | 4.645 | 862 |
| Shareholders Funds | -30.010 | 105 | 20.467 | 14.896 | 15.363 | 14.437 | 30.998 | 21.773 | 15.693 | 8.558 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 33.843 | 15.539 | 10.032 | 4.363 | 1.904 | 198 | 189 | 1.714 | 1.173 | 1.253 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Ager Med Ob-Gin Srl